Detalhe da pesquisa
1.
Fixed-duration ibrutinib plus venetoclax for first-line treatment of CLL: primary analysis of the CAPTIVATE FD cohort.
Blood
; 139(22): 3278-3289, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196370
2.
Chronic lymphocytic leukaemia Australasian consensus practice statement.
Intern Med J
; 53(9): 1678-1691, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37743239
3.
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
Lancet
; 397(10277): 892-901, 2021 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676628
4.
BTK inhibitor therapy is effective in patients with CLL resistant to venetoclax.
Blood
; 135(25): 2266-2270, 2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32244251
5.
Diagnosis, management and follow up of peripheral T-cell lymphomas: a consensus practice statement from the Australasian Lymphoma Alliance.
Intern Med J
; 52(10): 1806-1817, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668281
6.
Insight into del17p low-frequency subclones in chronic lymphocytic leukaemia (CLL): data from the Australasian Leukaemia and Lymphoma Group (ALLG)/CLL Australian Research Consortium (CLLARC) CLL5 trial.
Br J Haematol
; 193(3): 556-560, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33851417
7.
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL.
Blood
; 132(23): 2446-2455, 2018 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30287523
8.
Altered expression of metabolic pathways in CLL detected by unlabelled quantitative mass spectrometry analysis.
Br J Haematol
; 185(1): 65-78, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30656643
9.
Resistance to proteasome inhibitors and other targeted therapies in myeloma.
Br J Haematol
; 182(1): 11-28, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29676460
10.
Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
J Nanobiotechnology
; 16(1): 38, 2018 Apr 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653579
11.
Ibrutinib use, treatment duration, and concomitant medications in Australian patients with relapsed or refractory chronic lymphocytic leukaemia.
Br J Haematol
; 198(4): 790-793, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35702012
12.
Development of locus specific sub-clone separation by fluorescence in situ hybridization in suspension in chronic lymphocytic leukemia.
Cytometry A
; 91(11): 1088-1095, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29024486
13.
Management of high risk chronic lymphocytic leukaemia (CLL) patients in Australia.
Intern Med J
; 47 Suppl 6: 5-10, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29250930
14.
Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil.
Intern Med J
; 47 Suppl 4: 5-10, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28685928
15.
A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
Br J Haematol
; 192(3): e77-e81, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33278845
16.
T-Cell Large Granular Lymphocyte Leukemia in the Lower Eyelid.
Ophthalmic Plast Reconstr Surg
; 32(6): e126-e128, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-25198396
17.
Minimal change disease associated with newly diagnosed mantle cell lymphoma.
Ren Fail
; 36(4): 634-7, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24502759
18.
Immune checkpoint inhibitor-associated hemophagocytic lymphohistiocytosis in a patient with chronic lymphocytic leukemia.
Immunotherapy
; 15(18): 1531-1537, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37933523
19.
The Role of Cholesterol in Chronic Lymphocytic Leukemia Development and Pathogenesis.
Metabolites
; 13(7)2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37512506
20.
Real-world experience of Australian and New Zealand patients with chronic lymphocytic leukemia and mantle cell lymphoma accessing ibrutinib through a Named Patient Program.
Leuk Lymphoma
; 64(2): 312-318, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36423351